New regulations from New York's financial industry monitor—aimed at leveling the playing field for independent pharmacies by incorporating a series of market conduct rules for pharmacy benefit managers—offer the promise of stemming abuses in that market, and appear able to withstand any challenges, attorneys in the space said.